News Pfizer axes Alzheimer's and Parkinson's research Big pharma will continue developing tanezumab painkiller with Lilly
Partner Content Partner Content Potential Breakthrough Treatment for Erectile Dysfunction POTENTIAL BREAKTHROUGH TREATMENT FOR ED
Events Partner Content 3rd International Conference on Pancreatic Cancer and Liver ... Making Life Better: Fight Against Pancreatic Cancer
News Janssen's depression drug shows promise in phase 2 Ketamine may be best known as an anaesthetic illegally used as a party drug, but Janssen has shown that it could also be reformulated and used as a treatment for depression.
News Takeda interested in next-generation immuno-oncology deals Japanese firm wants to build presence in cancer
News Boehringer collaborates with Autifony on schizophrenia drug Deal could be worth 627.5 million euros
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
